Looking ahead, we remain confident in our strategy. And with our improved balance sheet, commitment to our dividend and now an additional $3 billion share repurchase authorization, we're positioned to return capital to shareholders. We are prioritizing investment in our strategic growth areas and in innovative solutions to meet our customers' needs today and tomorrow. We have been on a journey to simplify our portfolio and strengthen our core businesses, so we are positioned for broad-based sustainable growth as noted in the long-term targets we're announcing today. We are taking action to mitigate these impacts across the enterprise and we are reaffirming our FY '22 EPS guidance of $5.60 to $5.90 per share. As a result, we are lowering our FY '22 outlook for Medical segment profit to adjust for these increased headwinds. While we believe the majority of these elevated supply chain costs are temporary, we do not expect them to return to normalized levels this fiscal year. Recently, these pressures have rapidly escalated and we are experiencing significantly elevated product costs due to international freight and commodities. Our Medical segment continues to be impacted by the disruptions in the global supply chain that we called out last quarter. We believe our Pharma business, inclusive of our strategic growth areas of Specialty, Nuclear and Outcomes, is well positioned for growth in FY '22 and beyond.
In Pharma, we continue to see sequential volume improvement and are encouraged by the profit growth that we saw in the first quarter. As we continue to manage through the global pandemic, we're staying focused on the near-term priorities and long-term strategies to drive growth and momentum across our businesses. Our first quarter results were in line with our expectations. Thank you, Kevin and good morning, everyone. Michael Kaufmann - Chief Executive Officer With that, I'll now turn the call over to Mike. During the Q&A portion of today's call, we please ask that you try and limit yourself to one question, so that we can try and give everyone an opportunity. GAAP to non-GAAP reconciliations for all relevant periods can be found in the schedules attached to our press release. Please note that during our discussion today, our comments will be on a non-GAAP basis, unless they are specifically called out as GAAP.
CUSTOMER ORDER MANAGER SALARY CARDINAL HEALT FULL
Please refer to our SEC filings and the forward-looking statement slide at the beginning of our presentation for a full description of these risks and uncertainties. The matters addressed in the statements are subject to the risks and uncertainties that could cause actual results to differ materially from those projected or implied. Joining me today are Mike Kaufmann, Chief Executive Officer and Jason Hollar, Chief Financial Officer.ĭuring the call, we will be making forward-looking statements. You can find today's press release and presentation on the IR section of our website at ir. Today, we will discuss Cardinal Health's first quarter fiscal 2022 results. dba cvs pharmacy, cvs caremark specialty pharmacy, cvs caremark pharmacy, Caremark, LLC, Caremark Rx, CVS RX Services, Inc., CVS RX, CVS, Consumer Value Stores and cvs caremark.Good morning and welcome. The data presented on this page does not represent the view of CVS Health and its employees or that of Zippia.ĬVS Health may also be known as or be related to CVS HEALTH CORP, CVS HEALTH EMPLOYEE RELIEF FUND, CVS Health, CVS Health Corporation, Cvs Health, cvs pharmacy, cvs rx services, inc. None of the information on this page has been provided or approved by CVS Health. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets.
The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. The employee data is based on information from people who have self-reported their past or current employments at CVS Health. Zippia gives an in-depth look into the details of CVS Health, including salaries, political affiliations, employee data, and more, in order to inform job seekers about CVS Health.
0 kommentar(er)
